Bridge Clinical Research, Quorum and Kinetiq Leadership Spoke in Multiple Sessions at the PRIM&R AER Conference for Advancing Ethical Research

Leaders of Bridge Clinical Research, Quorum Review IRB and Kinetiq, the consulting and technology division of Quorum, were featured in multiple sessions in early November that covered emerging trends and best practices in clinical research at the Public Responsibility in Medicine and Research (PRIM&R) 2017 AER Conference, Nov. 5-8, 2017, in San Antonio.

"Quorum and Kinetiq provide the perfect pairing with institutions by building a community dedicated to the well-being of all people. A big part of this mission is to protect research-study participants through the highest-quality reviews. To this end, we were thrilled to have been invited to speak at PRIM&R’s AER Conference," says Quorum CEO Cami Gearhart. "We are confident we have shared our best practices and innovative thinking with colleagues."

Three speakers from Quorum and Kinetiq have been featured during the didactic sessions and workshop series on Nov. 6 at 1:45 p.m. Dr. Owen Garrick, a Quorum and PRIM&R board of directors member and president and COO of Bridge Clinical Research, was part of a hot topic workshop titled “Exploring and Enhancing Diversity Within our Compliance Committees.” Dominic Chiarelli, manager of Regulatory Affairs for Kinetiq, was part of a didactic panel session titled “The Evolving Clinical Research Enterprise: What Recent Legal and Regulatory Changes Mean to You.” Additionally, Dr. Stephen Rosenfeld, Quorum executive IRB chair and chair of SACHRP, was part of a didactic panel session on research in the digital world titled “IRB Review of Big Data Research.”

Another three speakers presented on Nov. 7. Dr. Stephen Rosenfeld returned as a key faculty member for the workshop session titled “A Dialogue With the Secretary’s Advisory Committee on Human Research Protections (SACHRP),” where he is the current committee chair. Also, James Riddle, Kinetiq vice president of client services, was part of a didactic panel session that included the president of AAHRPP titled “True Stories from the IRB and Their Impact on IRB Operations.” And Michelle Grienauer, Quorum senior regulatory attorney, was part of a double panel session with the director of OHRP and others titled “Return of Individual Research Results - Complex Considerations for a Not So Simple Request: Perspectives from Scientists, Subjects, and Regulators.”

On Nov. 8 — the last day of the PRIM&R AER Conference — Dr. Owen Garrick returned at 9:45 a.m. for an important plenary panel session titled “Race Matters: Ethical Challenges for the Use of Racial Categories in Research.” Finally, David Babaian, regulatory attorney for Kinetiq, participated in a workshop panel at 11:15 a.m. that looks ahead to research in the digital world titled “Clinical Trials Transformation Initiative (CTTI) Mobile Clinical Trials, Legal, and Regulatory Project.”

Quorum and Kinetiq was also in the exhibit hall to discuss how easy it is for institutions to designate Quorum as their single IRB (sIRB) of record or work with Kinetiq to build your own sIRB program.